An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Express Worries
However, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting substances of uncertain source.
Several experts stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, risking penalties, legal action or prison.
Platform Response and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization said it was dedicated to keeping the service secure and investing in strengthening compliance measures.
Online Marketplace Activities
Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for preparing or administering at residence.
Within moments of entering one group, a vendor posted WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Product Information and Pricing
Within these groups, posts show black plastic packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has already seen individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to potentially serious health risks”.